Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.

Abstract:

INTRODUCTION:Radioimmunotherapy (RIT) with monoclonal antibodies and their fragments labelled with radionuclides emitting α -particles, β-particles or Auger electrons have been used for many years in the development of anticancer strategies. While RIT has resulted in approved radiopharmaceuticals for the treatment of hematological malignancies, its use in solid tumors still remains challenging. AREAS COVERED:In this review, we discuss the exciting progress towards elucidating the potential of current and novel radioimmunoconjugates and address the challenges for translation into clinical practice. EXPERT OPINION:There are still technical and logistical challenges associated with the use of RIT in routine clinical practice, including development of novel and more specific targeting moieties, broader access α to α-emitters and better tailoring of pre-targeting approaches. Moreover, improved understanding of the heterogeneous nature of solid tumors and the critical role of tumor microenvironments will help to optimize clinical response to RIT by delivering sufficient radiation doses to even more radioresistant tumor cells.

journal_name

Expert Opin Drug Deliv

authors

Martins CD,Kramer-Marek G,Oyen WJG

doi

10.1080/17425247.2018.1378180

subject

Has Abstract

pub_date

2018-02-01 00:00:00

pages

185-196

issue

2

eissn

1742-5247

issn

1744-7593

journal_volume

15

pub_type

杂志文章,评审
  • In situ gel systems as 'smart' carriers for sustained ocular drug delivery.

    abstract:INTRODUCTION:In situ gel systems refer to a class of novel delivery vehicles, composed of natural, semisynthetic or synthetic polymers, which present the unique property of sol-gel conversion on receipt of biological stimulus. AREAS COVERED:The present review summarizes the latest developments in in situ gel technolog...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.665367

    authors: Agrawal AK,Das M,Jain S

    更新日期:2012-04-01 00:00:00

  • Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.

    abstract:INTRODUCTION:Research into oral delivery of biologics has a long and rich history but has not produced technologies used in the clinic. The area has evolved in terms of strategies to promote oral biologics delivery from early chemical absorption enhancers to nanomedicine to devices. Continued activity in this area is j...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2018.1504017

    authors: Vllasaliu D,Thanou M,Stolnik S,Fowler R

    更新日期:2018-08-01 00:00:00

  • Polymer-drug conjugates: recent progress on administration routes.

    abstract:INTRODUCTION:Polymer-drug conjugates are an important part of polymer therapeutics. Recently, they have been used as an appealing platform for drug delivery. As a delivery vector, the route of administration performs a serious impact on the accessibility of drug molecules to their respective target site and therapeutic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.912779

    authors: Pang X,Yang X,Zhai G

    更新日期:2014-07-01 00:00:00

  • Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.

    abstract:INTRODUCTION:Many new drug substances have low aqueous solubility which can cause poor bioavailability after oral administration. The application of solid dispersions is a useful method to increase the dissolution rate of these drugs and thereby improve their bioavailability. So far, several methods have been developed...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.598147

    authors: Srinarong P,de Waard H,Frijlink HW,Hinrichs WL

    更新日期:2011-09-01 00:00:00

  • Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain.

    abstract::Noninvasive, transient and local image-guided blood-brain barrier disruption can be accomplished using focused ultrasound exposure with intravascular injection of preformed microbubbles. MRI-guided blood-brain barrier disruption has been demonstrated and has been shown to heal in within a few hours after exposure. The...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.4.1.27

    authors: Hynynen K

    更新日期:2007-01-01 00:00:00

  • Innovative therapeutics: from molecules to medicines. 27 June-7 July 2004, Parma, Italy.

    abstract::The Socrates Intensive Programme offers annual courses focusing on the specific aspects of innovative therapeutics. The 2004 meeting was coordinated by the University of Parma and covered various subjects in the field of advanced drug delivery and pharmaceutical technology, including sessions on biopharmaceutics, phar...

    journal_title:Expert opinion on drug delivery

    pub_type:

    doi:10.1517/17425247.1.1.185

    authors: Jiskoot W,Santi P

    更新日期:2004-11-01 00:00:00

  • New biomaterials for the sustained release of nitric oxide: past, present and future.

    abstract::Nitric oxide (NO), the 1992 'Molecule of the Year', is the focus of immense medical and scientific exploration. Interest in NO has grown exponentially since the initial and relatively recent discovery that NO is the long sought after endothelial relaxing factor. There is intense research that is continuing to expose t...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903196743

    authors: Friedman A,Friedman J

    更新日期:2009-10-01 00:00:00

  • Current status and the future of buccal drug delivery systems.

    abstract:BACKGROUND:The delivery of drugs through the buccal mucosa has received a great deal of attention over the last two decades, and yet there are not many buccal delivery products available on the market. OBJECTIVE:This review outlines the advantages and disadvantages of buccal drug delivery, provides a historical perspe...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.5.531

    authors: Pather SI,Rathbone MJ,Senel S

    更新日期:2008-05-01 00:00:00

  • New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.

    abstract::dl-Methylphenidate (MPH) remains the most widely used pharmacological agent in the treatment of attention-deficit/hyperactivity disorder (ADHD). The predominantly dopaminergic mechanism of the psychostimulant actions has become more clearly defined. Neuroimaging and genetic studies are revealing the underlying neuropa...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.1.121

    authors: Patrick KS,González MA,Straughn AB,Markowitz JS

    更新日期:2005-01-01 00:00:00

  • Role of in vitro release models in formulation development and quality control of parenteral depots.

    abstract::This review article provides an assessment of advantages/limitations of the use of current in vitro release models to predict in vivo performance of parenteral sustained release products (injectable depots). As highlighted, key characteristics influencing the in vivo drug fate may vary with the route of administration...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903307431

    authors: Larsen C,Larsen SW,Jensen H,Yaghmur A,Ostergaard J

    更新日期:2009-12-01 00:00:00

  • The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.

    abstract:INTRODUCTION:Plasma protein binding with nanoparticles (NPs) occurs immediately upon their introduction into a physiological environment and is affected by the characteristics of NPs, including their composition, size, shape and surface properties. According to their specific functions, adsorbed proteins can be divided...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.877442

    authors: Gao H,He Q

    更新日期:2014-03-01 00:00:00

  • Cutting-edge technologies in colon-targeted drug delivery systems.

    abstract::Oral colon-targeted drug delivery systems have gained enormous attention among researchers in the last two decades. The significance of this site-specific drug delivery system can be measured by its usefulness for delivering a variety of therapeutic agents, both for the treatment of local diseases or for systemic ther...

    journal_title:Expert opinion on drug delivery

    pub_type: 社论

    doi:10.1517/17425247.2011.597739

    authors: Patel MM

    更新日期:2011-10-01 00:00:00

  • The use of reversible addition fragmentation chain transfer polymerization for drug delivery systems.

    abstract:INTRODUCTION:Reversible Addition Fragmentation Chain Transfer (RAFT) polymerisation is now an established tool for polymer chemists to create various polymer architectures with precise control over the molecular weight, and to install a variety of different moieties onto the polymer chain ends. Recently, there seems to...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.548381

    authors: Gregory A,Stenzel MH

    更新日期:2011-02-01 00:00:00

  • Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.

    abstract:INTRODUCTION:A nanosuspension or nanocrystal suspension is a versatile formulation combining conventional and innovative features. It comprises 100% pure drug nanoparticles with sizes in the nano-scale range, generally stabilized by surfactants or polymers. Nanosuspensions are usually obtained in liquid media with bott...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1043886

    authors: Leone F,Cavalli R

    更新日期:2015-01-01 00:00:00

  • Epidermal delivery of protein and DNA vaccines.

    abstract::Targeting vaccines to the skin epidermis results in the activation of an immune inductive site that is rich in antigen-presenting cells. The superficial location of the skin makes it accessible to vaccine delivery. However, it is difficult to access the epidermis using needle and syringe delivery, and vaccine antigens...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.2.227

    authors: Dean HJ

    更新日期:2005-03-01 00:00:00

  • Strategies for tumor-directed delivery of siRNA.

    abstract:INTRODUCTION:Current treatment of malignant tumors relies predominantly on chemotherapy delivering a single antineoplastic drug or a combination of two or more drugs intravenously. Problems with such treatments can include the killing of healthy cells, adverse side effects and chemoresistance. As cancer basically resul...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2011.554817

    authors: Chowdhury EH

    更新日期:2011-03-01 00:00:00

  • Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.

    abstract:INTRODUCTION:Carbohydrates are key participants in many biological processes including reproduction, inflammation, signal transmission and infection. Their biocompatibility and ability to be recognized by cell-surface receptors illustrate their potential therapeutic applications. αYet, they are not ideal candidates bec...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.902048

    authors: Sunasee R,Adokoh CK,Darkwa J,Narain R

    更新日期:2014-06-01 00:00:00

  • Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo.

    abstract:IMPORTANCE OF THE FIELD:Drug combinations have been the standard of care in the treatment of cancer for > 50 years. Typically, combination chemotherapy uses agents with non-overlapping toxicities which are escalated to their maximum tolerated dose. However, emerging evidence indicates that this approach may not be prov...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.538678

    authors: Dicko A,Mayer LD,Tardi PG

    更新日期:2010-12-01 00:00:00

  • Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils.

    abstract:BACKGROUND:The present work aims to formulate nanostructured lipid carriers (NLCs) exhibiting high skin deposition and high inherent antioxidant potential to repurpose the use of melatonin hormone and some antioxidant oils in the treatment of androgenic alopecia (AGA). RESEARCH DESIGN AND METHODS:NLCs were characteriz...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2018.1517740

    authors: Hatem S,Nasr M,Moftah NH,Ragai MH,Geneidi AS,Elkheshen SA

    更新日期:2018-10-01 00:00:00

  • Process optimization for the production of nanoparticles for drug delivery applications.

    abstract::Various techniques have been developed to prepare nanoparticles for the delivery of drugs. The implementation of these techniques for large-scale production is still in its infancy, as it requires defined steps which include excipient compatibility, process feasibility, formulation optimization, process optimization, ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902735806

    authors: Saraf S

    更新日期:2009-02-01 00:00:00

  • Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation.

    abstract:INTRODUCTION:Nanocomposite microparticles are intelligent carriers utilised for pulmonary drug delivery. These carriers are composed of drug-encapsulated nanoparticles dispersed in microstructures of polysaccharides. Upon administration, the inhaled microparticles can penetrate and be deposited deeply in the lung due t...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2016.1102224

    authors: Elsayed I,AbouGhaly MH

    更新日期:2016-01-01 00:00:00

  • Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials.

    abstract:INTRODUCTION:Development of efficient in vivo delivery systems remains a major challenge en route to clinical application of antisense technology, including RNA-cleaving molecules such as deoxyribozymes (DNAzymes). The mechanisms of oligonucleotide uptake and trafficking are clearly dependent on cell type and the type ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1266326

    authors: Fokina AA,Chelobanov BP,Fujii M,Stetsenko DA

    更新日期:2017-09-01 00:00:00

  • Controlled inhalation of aerosolised therapeutics.

    abstract::With the advent of new, and often expensive, therapeutics designed for aerosol delivery to the lung, there is a need to improve the targeting and efficiency of their delivery. By controlling breathing patterns associated with inhaled aerosols, it has been shown that deposition in the lung can be both maximised and tar...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2.4.763

    authors: Bennett WD

    更新日期:2005-07-01 00:00:00

  • Delivery methods for drugs used in the treatment of overactive bladder.

    abstract:INTRODUCTION:Overactive bladder affects a significant portion of the population and results in prescribing of numerous medications for its treatment. Traditional drug delivery systems used in therapy are associated with multiple commonly reported side effects. Adherence rates with use of these medications are low. It i...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2016.1130033

    authors: Scott K,Dmochowski RR,Padmanabhan P

    更新日期:2016-01-01 00:00:00

  • Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines.

    abstract:BACKGROUND:Pulmonary cell culture models for the development of new aerosol medicines are attracting increasing interest. Ease of handling, ethical acceptance and high explanatory power are the main advantages of cell culture systems in pulmonary drug research. OBJECTIVE:Pulmonary cell culture models are described and...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.6.641

    authors: Bur M,Lehr CM

    更新日期:2008-06-01 00:00:00

  • Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.

    abstract::Introduction: Poloxamer based in situ gelling systems offer numerous advantages in drug delivery; however, their application as prolonged-release delivery platforms is limited mainly due to their weak mechanical properties and the interconnected aqueous network causing fast gel erosion and drug diffusion.Area covered:...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1731469

    authors: Abdeltawab H,Svirskis D,Sharma M

    更新日期:2020-04-01 00:00:00

  • Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.

    abstract:INTRODUCTION:A major problem with conventional antitumor therapeutics is nonselective delivery of cytotoxic drugs to normal vital organs and tissues but little delivery to tumor tissues. AREAS COVERED:Here, the authors describe the tumor selective delivery of antitumor drugs by taking advantage of nano-sized drugs and...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.955011

    authors: Nakamura H,Fang J,Maeda H

    更新日期:2015-01-01 00:00:00

  • Targeted delivery of drugs for liver fibrosis.

    abstract::Liver fibrosis and its end stage disease cirrhosis are a major cause of mortality and morbidity around the world. There is no effective pharmaceutical intervention for liver fibrosis at present. Many drugs that show potent antifibrotic activities in vitro often show only minor effects in vivo because of insufficient c...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902936834

    authors: Li F,Wang JY

    更新日期:2009-05-01 00:00:00

  • Technology-derived storage solutions for stabilizing insulin in extreme weather conditions I: the ViViCap-1 device.

    abstract:BACKGROUND:Injectable life-saving drugs should not be exposed to temperatures <4°C/39°F or >30°C/86°F. Frequently, weather conditions exceed these temperature thresholds in many countries. Insulin is to be kept at 4-8°C/~ 39-47°F until use and once opened, is supposed to be stable for up to 31 days at room temperature ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2017.1316261

    authors: Pfützner A,Pesach G,Nagar R

    更新日期:2017-06-01 00:00:00

  • Endothelial nanomedicine for the treatment of pulmonary disease.

    abstract:INTRODUCTION:Even though pulmonary diseases are among the leading causes of morbidity and mortality in the world, exceedingly few life-prolonging therapies have been developed for these maladies. Relief may finally come from nanomedicine and targeted drug delivery. AREAS COVERED:Here, we focus on four conditions for w...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.961418

    authors: Brenner JS,Greineder C,Shuvaev V,Muzykantov V

    更新日期:2015-02-01 00:00:00